Cointime

  • News
  • Insight
  • Currencies
  • Columns
  • Events
  • Bitcoin $66,749.36 -4.96%
  • Ethereum $1,857.68 -5.76%
  • BNB $647.08 -5.26%
  • Optimism $0.12 -0.86%
  • Arbitrum $0.09 -7.78%
  • Solana $74.49 -6.51%
  • Polygon $0.22 +2.77%
  • Cosmos $1.85 -1.18%
  • Avalanche $8.21 -5.69%
  • Bitcoin $66,749.36 -4.96%
  • Ethereum $1,857.68 -5.76%
  • BNB $647.08 -5.26%
  • Optimism $0.12 -0.86%
  • Arbitrum $0.09 -7.78%
  • Solana $74.49 -6.51%
  • Polygon $0.22 +2.77%
  • Cosmos $1.85 -1.18%
  • Avalanche $8.21 -5.69%
Home / Nimbus Therapeutics / investors

Nimbus Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
7
17
Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.
Investor Name Lead Investor Funding Round
Access Biotechnology - Series Unknown
Atlas Venture - Series Unknown
Bain Capital Life Sciences - Series Unknown
Bill Gates - Series Unknown
Biotechnology Value Fund - Series Unknown
Lightstone Ventures - Series Unknown
Pfizer Venture Investments - Series Unknown
RA Capital Management - Series Unknown
SR One - Series Unknown
SV Health Investors - Series Unknown
Commodore Capital - Series Unknown
Logos Capital - Series Unknown
Surveyor Capital - Series Unknown
BVF Partners - Series Unknown
Lilly Ventures - Series C
Schrödinger - Series C
Richard Friesner - Seed

Contact

Cambridge,Massachusetts,United States
(857) 999-2009
Cointime
Insight
  • Latest News
  • Web3
  • Blockchain
  • Metaverse
  • Bitcoin
  • Ethereum
  • NFT
  • DeFi
Features
  • Startups
  • Research
  • Technology
  • Topics
  • Columns
  • Currencies
  • Events
  • Tags
RSS
  • Latest News
  • Startups
  • Research
  • Technology
Company
  • About
  • Advertise
  • Disclaimers
  • © 2023 Cointime. All rights reserved.
  • Privacy Policy
  • Terms & Conditions